Structure-Based Design of Potent, Conformationally Constrained Smac Mimetics
- 1 December 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 126 (51) , 16686-16687
- https://doi.org/10.1021/ja047438+
Abstract
A successful structure-based design and synthesis of a class of highly potent conformationally constrained Smac mimetics is described. The most potent compound has a Ki value of 25 nM binding to the XIAP BIR3 protein and is 23 times more potent than natural Smac peptides. These potent Smac mimetics can serve as powerful chemical and pharmacological tools to further elucidate the role of Smac and its cellular binding partners in apoptosis regulation and may be developed as a new class of anti-cancer drugs.Keywords
This publication has 9 references indexed in Scilit:
- The Emergence of Competition Between Model ProtocellsScience, 2004
- Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarizationAnalytical Biochemistry, 2004
- Upstream Regulatory Role for XIAP in Receptor-Mediated ApoptosisMolecular and Cellular Biology, 2004
- Discovery of Embelin as a Cell-Permeable, Small-Molecular Weight Inhibitor of XIAP through Structure-Based Computational Screening of a Traditional Herbal Medicine Three-Dimensional Structure DatabaseJournal of Medicinal Chemistry, 2004
- Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivoNature Medicine, 2002
- A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosisNature, 2001
- Structural basis of IAP recognition by Smac/DIABLONature, 2000
- Erratum: correction: Digital selection and analogue amplification coexist in a cortex-inspired silicon circuitNature, 2000
- Identification of DIABLO, a Mammalian Protein that Promotes Apoptosis by Binding to and Antagonizing IAP ProteinsCell, 2000